InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Forte Biosciences, Inc.

FBRX Clue Score28
United States Fiscal year ends December CIK 0001419041
$76.99 +0.00% Close, 27 Aug 2026
Alert on the numbers Alert on insider trades
Price $76.99 +173.11% Close, 27 Aug 2026

Closing prices at the end of each trading day, from 13 Apr 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−31.7Net income−33.5Fiscal year 2017Revenue0.0 −16.3%Operating income−37.6Net income−38.9Fiscal year 2018Revenue18.0 +43,890.2%Operating income−45.9Net income−49.0Fiscal year 2019Revenue0.0 −99.8%Operating income−4.1Net income−4.1Fiscal year 2020Operating income−46.3Net income−46.5Fiscal year 2021Operating income−21.5Net income−21.7EPS, diluted−1.55Fiscal year 2022Operating income−13.9Net income−13.9EPS, diluted−0.80Fiscal year 2023Operating income−32.5Net income−31.5EPS, diluted−24.92Fiscal year 2024Operating income−36.6Net income−35.5EPS, diluted−12.17Fiscal year 2025Operating income−70.7Net income−69.4EPS, diluted−4.71
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 18.0 0.0 n/a n/a n/a n/a n/a n/a
Growth −16.3% +43,890.2% −99.8%
Operating income −31.7 −37.6 −45.9 −4.1 −46.3 −21.5 −13.9 −32.5 −36.6 −70.7
Net income −33.5 −38.9 −49.0 −4.1 −46.5 −21.7 −13.9 −31.5 −35.5 −69.4
Growth
EPS, diluted n/a n/a n/a n/a n/a −1.55 −0.80 −24.92 −12.17 −4.71
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−64,673.5%Net margin−68,322.4%Free cash flow margin−61,355.1%Fiscal year 2017Operating margin−91,775.6%Net margin−94,948.8%Free cash flow margin−77,531.7%Fiscal year 2018Operating margin−254.2%Net margin−271.4%Free cash flow margin−202.0%Fiscal year 2019Operating margin−11,288.9%Net margin−11,302.8%Free cash flow margin−8,147.2%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −64,673.5% −91,775.6% −254.2% −11,288.9% n/a n/a n/a n/a n/a n/a
Net margin −68,322.4% −94,948.8% −271.4% −11,302.8% n/a n/a n/a n/a n/a n/a
Free cash flow margin −61,355.1% −77,531.7% −202.0% −8,147.2% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−29.5Capital expenditure−0.5Free cash flow−30.1Fiscal year 2017Operating cash flow−31.1Capital expenditure−0.7Free cash flow−31.8Fiscal year 2018Operating cash flow−34.5Capital expenditure−2.0Free cash flow−36.4Fiscal year 2019Operating cash flow−2.8Capital expenditure−0.2Free cash flow−2.9Fiscal year 2020Operating cash flow−18.4Fiscal year 2021Operating cash flow−16.7Fiscal year 2022Operating cash flow−8.2Fiscal year 2023Operating cash flow−28.7Capital expenditure−0.1Free cash flow−28.8Fiscal year 2024Operating cash flow−30.7Capital expenditure−0.0Free cash flow−30.8Fiscal year 2025Operating cash flow−50.9Capital expenditure−0.1Free cash flow−51.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −29.5 −31.1 −34.5 −2.8 −18.4 −16.7 −8.2 −28.7 −30.7 −50.9
Capital expenditure −0.5 −0.7 −2.0 −0.2 n/a n/a n/a −0.1 −0.0 −0.1
Free cash flow −30.1 −31.8 −36.4 −2.9 n/a n/a n/a −28.8 −30.8 −51.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash5.5Total debt10.2Net cash (debt)−4.7Shareholders’ equity−124.4Fiscal year 2017Cash35.9Total debt3.6Net cash (debt)32.3Shareholders’ equity71.1Debt to equity0.05Fiscal year 2018Cash40.8Total debt26.2Net cash (debt)14.6Shareholders’ equity−0.7Fiscal year 2019Cash6.9Shareholders’ equity−4.8Fiscal year 2020Cash58.8Shareholders’ equity59.0Fiscal year 2021Cash42.0Shareholders’ equity41.5Fiscal year 2022Cash41.1Shareholders’ equity38.8Fiscal year 2023Cash37.1Shareholders’ equity35.3Fiscal year 2024Cash22.2Shareholders’ equity52.5Fiscal year 2025Cash77.0Shareholders’ equity61.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 5.5 35.9 40.8 6.9 58.8 42.0 41.1 37.1 22.2 77.0
Total debt 10.2 3.6 26.2 n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) −4.7 32.3 14.6 n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity −124.4 71.1 −0.7 −4.8 59.0 41.5 38.8 35.3 52.5 61.0
Debt to equity n/a 0.05 n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−64,673.5% −91,775.6% −254.2% −11,288.9% n/a n/a n/a n/a n/a n/a
−68,320.4% −94,946.3% −262.0% −176,430.6% n/a n/a n/a n/a n/a n/a
−68,322.4% −94,948.8% −271.4% −11,302.8% n/a n/a n/a n/a n/a n/a
−61,355.1% −77,531.7% −202.0% −8,147.2% n/a n/a n/a n/a n/a n/a
Spending
55,546.9% 71,007.3% 283.2% 125,830.6% n/a n/a n/a n/a n/a n/a
9,226.5% 20,868.3% 71.0% 3,833.3% n/a n/a n/a n/a n/a n/a
1,071.4% 1,597.6% 10.9% 450.0% n/a n/a n/a n/a n/a n/a
Returns
n/a −54.8% n/a n/a −78.8% −52.2% −35.8% −89.1% −67.6% −113.7%
−94.7% −42.3% −47.5% −53.1% −75.9% −50.1% −33.0% −80.7% −57.6% −83.8%
Balance and payout
n/a 0.05 n/a n/a n/a n/a n/a n/a n/a n/a
80.2% 22.8% 43.6% 226.1% n/a n/a n/a n/a 14.8% 26.3%